Inactive Instrument

News CEL-SCI Corporation Nyse

Equities

US1508374097

End-of-day quote Nyse Other stock markets
- ^USD	-

Apr. 23	CEL-SCI Corporation Appoints Mario Gobbo as Board of Directors	CI
Feb. 14	CEL-SCI Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CEL-SCI Appoints Mario Gobbo to Its Board of Directors	Apr. 23	BU
CEL-SCI Corporation Appoints Mario Gobbo as Board of Directors	Apr. 23	CI
CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology	Mar. 19	BU
CEL-SCI Corporation Issues Letter to Shareholders	Mar. 06	BU
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results	Feb. 15	BU
Cel-Sci: Fiscal Q1 Earnings Snapshot	Feb. 14	AQ
CEL-SCI Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 14	CI
Cel-Sci Closes $7.8 Million Share Offering	Feb. 13	MT
CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock	Feb. 13	BU
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock	Feb. 12	AQ
Health Care Slips on Rotation to High-Risk Sectors -- Health Care Roundup	Feb. 09	DJ
Cel-Sci Prices $7.8 Million Public Offering of Common Shares	Feb. 09	MT
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock	Feb. 09	BU
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head and Neck Cancer Drug	Feb. 07	AQ
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug	Feb. 06	BU
CEL-SCI Corporation Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug	Feb. 06	CI
European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path towards Marketing Authorization for Multikine	Feb. 01	AQ
Sector Update: Health Care Stocks Mixed Late Wednesday Afternoon	Jan. 31	MT
Sector Update: Health Care Stocks Gain in Afternoon Trading	Jan. 31	MT
Cel-Sci Receives Pediatric Requirements Waiver for Multikine From European Medicines Agency	Jan. 31	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News CEL-SCI Corporation Nyse

Equities

US1508374097

Summary

Filters